The cost of plasma depends on which side of the transaction you’re asking about. If you’re donating, you can expect $30 to $70 per visit at most U.S. plasma centers, with some paying $100 or more. If you’re a hospital buying plasma for transfusions, a single unit of fresh frozen plasma runs about $41 on average. And if plasma gets processed into therapeutic products like albumin or immunoglobulin, the final price can reach hundreds or even thousands of dollars.
What Plasma Donors Get Paid
Plasma centers in the U.S. pay donors (technically called “compensated donors”) between $30 and $70 per donation as a baseline. Some centers are now paying $100 or more per visit as of mid-2025. You can donate up to twice per week, with at least 48 hours between sessions, which means committed donors who show up regularly can earn up to $1,000 a month.
The biggest payouts go to new donors. Centers front-load their compensation to get people through the door and through their first several visits. CSL Plasma advertises up to $750 in your first month. BioLife Plasma Services offers up to $750 at select locations for new donors as well. Octapharma promotes earning “hundreds of dollars” in your first 35 days. After the introductory period, per-visit pay typically drops, though loyalty programs and periodic promotions can push monthly earnings to around $400 or more.
Payment varies by location. Centers in areas with fewer donors or higher demand tend to pay more. College towns, for example, often have competitive rates because plasma companies are competing for the same pool of young, healthy donors.
What Hospitals Pay Per Unit
Fresh frozen plasma, the product used in hospital transfusions, costs medical facilities about $41 per unit on average. That figure comes from a 2022 financial analysis published in the American Journal of Clinical Pathology. A single unit is roughly 200 to 250 milliliters, collected from one donor.
That $41 covers the acquisition cost from a blood bank or collection organization, but it doesn’t capture the full expense hospitals absorb. Storage requires specialized freezers that maintain temperatures at or below negative 18 degrees Celsius. Thawing plasma before use takes 20 to 30 minutes and requires trained staff. Cross-matching, compatibility testing, and administering the transfusion all add labor and overhead. The total cost to a hospital for delivering one unit of plasma to a patient is significantly higher than the sticker price.
Raw Plasma on the Global Market
Before plasma gets turned into specific therapies, it trades as a bulk commodity called “source plasma.” In the U.S., a liter of source plasma cost about $198 as of 2021, up 27% from $156 in 2016. European prices tracked a similar increase, rising from €110 to €139 per liter over the same period. These prices have likely continued climbing since then, driven by rising donor compensation and growing global demand for plasma-derived medicines.
The U.S. supplies the vast majority of the world’s source plasma. Paid donation is legal here, unlike in many countries that rely on unpaid voluntary donors. That policy difference is why American plasma centers collect far more per capita than facilities in Europe or Asia, and why U.S. source plasma gets exported globally.
Why Finished Products Cost So Much More
The real expense emerges after collection. Plasma fractionation, the industrial process of separating plasma into its individual protein components, is capital-intensive and heavily regulated. A single liter of plasma contains albumin, immunoglobulins, clotting factors, and other proteins, each of which must be isolated, purified, tested for pathogens, and packaged.
The price differences are dramatic. A 50-milliliter vial of 25% human albumin solution costs about $108 at retail. A 100-milliliter vial runs around $207. Albumin is one of the more affordable plasma-derived products. Immunoglobulin therapies, used to treat immune deficiencies and autoimmune conditions, can cost patients thousands of dollars per infusion. A typical course of treatment involves infusions every few weeks, and annual costs for some patients exceed $30,000 to $70,000 depending on dosage and insurance coverage.
Clotting factor concentrates for hemophilia are even more expensive, with some patients facing annual treatment costs in the hundreds of thousands of dollars. These prices reflect the sheer volume of plasma required (some products need plasma pooled from thousands of donors), the complexity of manufacturing, and the limited number of companies with the facilities to do it.
What Patients Actually Pay
If you’re receiving a plasma transfusion in a hospital, your out-of-pocket cost depends almost entirely on your insurance. Most private insurance plans cover plasma transfusions as part of inpatient care, subject to your deductible and copay structure. Medicare also covers medically necessary blood products, though patients may be responsible for the cost of the first three units of blood or blood products per calendar year unless they can arrange replacement donors.
For plasma-derived therapies like immunoglobulin infusions, insurance coverage varies widely. Some plans cover home infusion, which tends to be less expensive than hospital-based treatment. Others require prior authorization or limit the number of approved infusions. Without insurance, even a single infusion can cost $5,000 to $10,000 or more, making these among the most expensive recurring treatments in medicine.
The gap between what a donor receives ($35 to $70 per session) and what a patient pays (potentially thousands per treatment) reflects the long, regulated supply chain that transforms a biological fluid into a life-saving pharmaceutical product. Every step, from collection to fractionation to distribution, adds cost, and the global demand for plasma-derived therapies continues to outpace supply.